Allergan Expands GI Reach With Linaclotide Deal
This article was originally published in Scrip
Executive Summary
Allergan PLC is bolstering its gastrointestinal portfolio by purchasing rights from the Spanish drug maker Almirall SA to sell US-based Ironwood Pharmaceuticals, Inc's GI drug linaclotide in the 28-nation European Union, Switzerland, Turkey and in the Commonwealth of Independent States (CIS) and Mexico.